Philips shows new ultrasound, decision support tools, patient monitors

Royal Philips Electronics is showing several new products at this week's meeting of the  American Heart Association in Dallas, including a the company's new HD11 XE ultrasound system and ST Map, a clinical decision support tool available on Philips IntelliVue patient monitors, the company said.
   
The Philips HD11 XE is a compact "all-in-one'" system that puts a wide range of necessary tools - diagnosis, assessment, procedure guidance, and monitoring - at read use for clinicians. The system is designed to work with a broad range of transducers.

Additionally, the HD11 XE (extreme edition) adds features such as a flat-panel monitor, improved ergonomics and QLAB quantification software to help physicians which provide an extensive, non-invasive assessment of cardiac anatomy and function.

The ST segment of the electrocardiographic tracing is the portion that can indicate myocardial ischemia, or less-than-normal blood flow to the heart. Standard tabular displays of the data can be difficult for clinicians to interpret. Thus, Philips new ST Map graphical display is designed to remedy this problem. It displays ST segment changes, with the goal of helping clinicians recognize patterns and track patient progress more easily.

Additionally, Philips will demonstrate the MRx defibrillator/monitor with Q-CPR.  Q-CPR has been cleared by the FDA and provides real-time cardiopulmonary resuscitation (CPR) monitoring and feedback for advanced life support (ALS) trained responders. Also, the Philips HeartStart FR2+ with SMART CPR is Automated External Defibrillator (AED) that advises the user whether to provide an immediate defibrillation shock, or CPR followed by a shock, to a victim of sudden cardiac arrest (SCA), Philips said.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.